Organ Transplant Immunosuppressant Drugs Market Projected To Garner Significant Revenues By 2023 End by poojam · August 27 Trysten Hill Jersey , 2018
The global organ transplant immunosuppressant drugs market has been going through a rough patch since last few years. The high cost of organ transplantation, coupled with increasing incidences of infection post-transplant, has affected the worldwide market for organ transplant immunosuppressant drugs significantly in recent 2014, the global organ transplant immunosuppressant drugs market stood at US$5.1 bn. Impacted deeply by the dearth of donor organs, this market is likely to further decline at a -5.0% CAGR between 2015 and 2023 and relegate to US$3.2 bn by 2023.
Antibody and Bone Marrow Transplant to Emerge as Fastest Growing Markets in Respective Categories
The global market for organ transplant immunosuppressant drugs is broadly classified on the basis of drug class Taco Charlton Jersey , transplants, and regional distribution. Calcineurin inhibitors, mTOR inhibitors, anti-proliferative agents, steroids Michael Gallup Jersey , and antibodies are the key segments of the organ transplant immunosuppressant drugs market based on drug class.
The calcineurin inhibitors segment dominated the global market in 2014, valuing US$2,304.0 mn in total. However, the antibody market is likely to post the fastest growth in the coming markets for kidney transplant, liver transplant Leighton Vander Esch Jersey , lungs transplant, bone marrow transplant, heart transplant, and other multi-visceral and intestinal organs transplant are the main segments of the worldwide organ transplant immunosuppressant drugs market.
Request for Sample Copy of Report @聽 ;rep_id=1967
The kidney transplant market is the dominant segment of the overall market, accounting for a majority share. The market segment is likely to retain its leadership on account of the adequate availability of kidney compared to other organs. On the other hand the bone marrow transplant market is likely to expand at the fastest rate in the near future.
Asia Pacific to Report Fastest Growth in Global Organ Transplant Immunosuppressant Drugs Market
North America Demarcus Lawrence Jersey , Latin America, Europe, Asia Pacific, and the Rest of the World are the traditional regional markets for organ transplant immunosuppressant drugs. North America, particularly the U.S. is the largest organ transplant immunosuppressant drugs market across the globe. In 2013 Amari Cooper Jersey , the U.S. emerged as the most lucrative market for organ transplantation, wherein kidney transplantation acquired majority of the market and was followed by transplantations of heart and liver, according to a report published by the WHO.
The organ transplant immunosuppressant drugs market in Europe and Asia are also witnessing robust development. China has occupied the largest share of the Asia Pacific market for organ transplant immunosuppressant dominance of North America on the global organ transplant immunosuppressant drugs market can be attributed to the immense technical development and the availability of advanced surgical techniques as well as efficient immunosuppressive drugs. The increasing rate of success of organ transfer procedures has also aided the growth of the organ transplant immunosuppressant drugs market.
On the other hand, the rise in the medical tourism for organ transplantation in Asia Pacific, fueled by cost-efficiency of emerging economies Dak Prescott Jersey , is propelling the Asia Pacific market for organ transplant immunosuppressant drugs. However, analysts expect a decline in the growth rate of this region on account of imbalance between the demand and the supply of organs to be transplanted. Additionally, the rising incidence of infection after transplant is likely to hamper the growth of this regional market in the coming years.
Global Organ Transplant Immunosuppressant Drugs Market: Key Players
F. Hoffmann-La Roche Ltd., Allergan plc, Sanofi S.A. Ezekiel Elliott Jersey , Bristol-Myers Squibb Co., AbbVie Inc., Pfizer Inc., Astellas Pharma Inc., Novartis AG Emmitt Smith Jersey , Veloxis Pharmaceuticals AS, and GlaxoSmithKline plc are some of the major organ transplant immunosuppressant drugs manufacturers across the globe.
More Trending Reports by Transparency Market Research 鈥?p>
Thema drucken
15.10.2019 10:27
Antworten
